Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02861352 · ClinicalTrials.gov registry record · NA

An Evaluation of Zinc Status Biomarkers

A NA study, sponsored by UCSF Benioff Children's Hospital Oakland.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT02861352: Completed NA study, sponsored by UCSF Benioff Children's Hospital Oakland.

NCT02861352 is a NA study that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02861352, a NA study, has completed, sponsored by UCSF Benioff Children's Hospital Oakland.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effect of a moderate decrease in dietary zinc on DNA strand breaks and other cellular zinc biomarkers.

Primary Outcome

Baseline measurements were made upon entry into the study. Subsequent measurements were made after 2 weeks on a low zinc diet (6 mg/d), 4 weeks on a moderate zinc intake (10 mg/d) and after 3 weeks of consuming a 25 mg zinc supplement.

Interventions

  • OTHER Diet zinc

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2011-03
Est. Completion 2015-02
Phase NA

What the finished NCT02861352 record still lists

NCT02861352 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Diet zinc is the first listed.

NCT02861352 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02861352 about?

NCT02861352 is a clinical study titled "An Evaluation of Zinc Status Biomarkers". The purpose of this study is to determine the effect of a moderate decrease in dietary zinc on DNA strand breaks and other cellular zinc biomarkers.

What is the current status of trial NCT02861352?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2011-03. Estimated completion is 2015-02.

What interventions are being tested in trial NCT02861352?

The interventions under investigation include: Diet zinc (OTHER).

Who is sponsoring clinical trial NCT02861352?

This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02861352's enrollment target sits among peer trials

18 1863rd of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02861352, the US trial registry maintained by the National Library of Medicine. NCT02861352 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.